| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 142801* | 2009 |
| Cochrane handbook for systematic reviews of interventions JPT Higgins, J Thomas, J Chandler, M Cumpston, T Li, MJ Page, ... John Wiley & Sons, 2019 | 54738 | 2019 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Journal of clinical epidemiology 62 (10), e1-e34, 2009 | 41611 | 2009 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... Bmj 343, 2011 | 22778 | 2011 |
| Meta-analysis of observational studies in epidemiology: a proposal for reporting DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie, ... Jama 283 (15), 2008-2012, 2000 | 18713 | 2000 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Systematic reviews 10 (1), 1-11, 2021 | 18066 | 2021 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Systematic reviews 4 (1), 1-9, 2015 | 16260 | 2015 |
| PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation AC Tricco, E Lillie, W Zarin, KK O'Brien, H Colquhoun, D Levac, D Moher, ... Annals of internal medicine 169 (7), 467-473, 2018 | 10581 | 2018 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials D Moher, KF Schulz, DG Altman, CONSORT Group* Annals of internal medicine 134 (8), 657-662, 2001 | 10387* | 2001 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Bmj 349, 2015 | 9133 | 2015 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 5639 | 2014 |
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie, DF Stroup, ... The Lancet 354 (9193), 1896-1900, 1999 | 5356 | 1999 |
| Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BJ Shea, JM Grimshaw, GA Wells, M Boers, N Andersson, C Hamel, ... BMC medical research methodology 7 (1), 1-7, 2007 | 4699 | 2007 |
| Improving the quality of reporting of randomized controlled trials: the CONSORT statement C Begg, M Cho, S Eastwood, R Horton, D Moher, I Olkin, R Pitkin, ... Jama 276 (8), 637-639, 1996 | 4673 | 1996 |
| AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel, J Moran, D Moher, ... bmj 358, 2017 | 4666 | 2017 |
| Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ... Bmj 343, 2011 | 4611 | 2011 |
| The revised CONSORT statement for reporting randomized trials: explanation and elaboration DG Altman, KF Schulz, D Moher, M Egger, F Davidoff, D Elbourne, ... Annals of internal medicine 134 (8), 663-694, 2001 | 4495 | 2001 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 4435 | 2013 |
| Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group Physical therapy 89 (9), 873-880, 2009 | 4244* | 2009 |
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials KF Schulz, DG Altman, D Moher, CONSORT Group* Annals of internal medicine 152 (11), 726-732, 2010 | 3949 | 2010 |
